FDA Approves New Therapy for Dravet Syndrome
Fintepla labelling includes a boxed warning stating the drug is associated with valvular heart disease (VHD) and pulmonary…
Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
